1 Min Read
Sept 12 (Reuters) - Diamedica Inc
* Diamedica announces regulatory clearance to initiate bridging clinical trial for DM199 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.